Skip to main content
Top
Published in: Malaria Journal 1/2006

Open Access 01-12-2006 | Methodology

Prediction of solubility on recombinant expression of Plasmodium falciparum erythrocyte membrane protein 1 domains in Escherichia coli

Authors: Sanjay Ahuja, Satpal Ahuja, Qijun Chen, Mats Wahlgren

Published in: Malaria Journal | Issue 1/2006

Login to get access

Abstract

Background

Cellular interactions elicited by Plasmodium falciparum erythrocyte membrane protein antigen 1 (PfEMP1) are brought about by multiple DBL (Duffy binding like), CIDR (cysteine-rich interdomain region) and C2 domain types. Elucidation of the functional and structural characteristics of these domains is contingent on the abundant availability of recombinant protein in a soluble form. A priori prediction of PfEMP1 domains of the 3D7 genome strain, most likely to be expressed in the soluble form in Escherichia coli was computed and proven experimentally.

Methods

A computational analysis correlating sequence-dependent features to likelihood for expression in soluble form was computed and predictions were validated by the colony filtration blot method for rapid identification of soluble protein expression in E. coli.

Results

Solubility predictions for all constituent PfEMP1 domains in the decreasing order of their probability to be expressed in a soluble form (% mean solubility) are as follows: ATS (56.7%) > CIDR1α (46.8%) > CIDR2β (42.9%) > DBL2-4γ (31.7%) > DBL2β + C2 (30.6%) > DBL1α (24.9%) > DBL2-7ε (23.1%) > DBL2-5δ (14.8%). The length of the domains does not correlate to their probability for successful expression in the soluble form. Immunoblot analysis probing for soluble protein confirmed the differential in solubility predictions.

Conclusion

The acidic terminal segment (ATS) and CIDR α/β domain types are suitable for recombinant expression in E. coli while all DBL subtypes (α, β, γ, δ, ε) are a poor choice for obtaining soluble protein on recombinant expression in E. coli. This study has relevance for researchers pursuing functional and structural studies on PfEMP1 domains.
Appendix
Available only for authorised users
Literature
1.
go back to reference Flick K, Ahuja S, Chene A, Bejarano MT, Chen Q: Optimized expression of Plasmodium falciparum erythrocyte membrane protein 1 domains in Escherichia coli. Malar J. 2004, 3: 50-10.1186/1475-2875-3-50.PubMedCentralCrossRefPubMed Flick K, Ahuja S, Chene A, Bejarano MT, Chen Q: Optimized expression of Plasmodium falciparum erythrocyte membrane protein 1 domains in Escherichia coli. Malar J. 2004, 3: 50-10.1186/1475-2875-3-50.PubMedCentralCrossRefPubMed
2.
go back to reference Sørensen HP, Mortensen KK: Advanced genetic strategies for recombinant protein expression in Escherichia coli. J Biotechnol. 2005, 115: 113-128. 10.1016/j.jbiotec.2004.08.004.CrossRefPubMed Sørensen HP, Mortensen KK: Advanced genetic strategies for recombinant protein expression in Escherichia coli. J Biotechnol. 2005, 115: 113-128. 10.1016/j.jbiotec.2004.08.004.CrossRefPubMed
3.
go back to reference Dale GE, Broger C, Langen H, D'Arcy A, Stuber D: Improving protein solubility through rationally designed amino acid replacements: solubilization of the trimethoprim-resistant type S1 dihydrofolate reductase. Protein Eng. 1994, 7: 933-939.CrossRefPubMed Dale GE, Broger C, Langen H, D'Arcy A, Stuber D: Improving protein solubility through rationally designed amino acid replacements: solubilization of the trimethoprim-resistant type S1 dihydrofolate reductase. Protein Eng. 1994, 7: 933-939.CrossRefPubMed
4.
go back to reference Jenkins TM, Hickman AB, Dyda F, Ghirlando R, Davies DR, Craigie R: Catalytic domain of human immunodeficiency virus type 1 integrase: Identification of a soluble mutant by systematic replacement of hydrophobic residues. Proc Natl Acad Sci USA. 1995, 92: 6057-6061. 10.1073/pnas.92.13.6057.PubMedCentralCrossRefPubMed Jenkins TM, Hickman AB, Dyda F, Ghirlando R, Davies DR, Craigie R: Catalytic domain of human immunodeficiency virus type 1 integrase: Identification of a soluble mutant by systematic replacement of hydrophobic residues. Proc Natl Acad Sci USA. 1995, 92: 6057-6061. 10.1073/pnas.92.13.6057.PubMedCentralCrossRefPubMed
5.
go back to reference Chiti F, Calamai M, Taddei N, Stefani M, Ramponi G, Dobson CM: Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc Natl Acad Sci USA. 2002, 99: 16419-16426. 10.1073/pnas.212527999.PubMedCentralCrossRefPubMed Chiti F, Calamai M, Taddei N, Stefani M, Ramponi G, Dobson CM: Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc Natl Acad Sci USA. 2002, 99: 16419-16426. 10.1073/pnas.212527999.PubMedCentralCrossRefPubMed
6.
go back to reference Pedelacq JD, Cabantous S, Tran T, Terwilliger TC, Waldo GS: Engineering and characterization of a superfolder green fluorescent protein. Nat Biotechnol. 2006, 24: 79-88. 10.1038/nbt1172.CrossRefPubMed Pedelacq JD, Cabantous S, Tran T, Terwilliger TC, Waldo GS: Engineering and characterization of a superfolder green fluorescent protein. Nat Biotechnol. 2006, 24: 79-88. 10.1038/nbt1172.CrossRefPubMed
7.
go back to reference Wilkinson DL, Harrison RG: Predicting the solubility of recombinant proteins in Escherichia coli. Biotechnology (NY). 1991, 9: 443-448. 10.1038/nbt0591-443.CrossRef Wilkinson DL, Harrison RG: Predicting the solubility of recombinant proteins in Escherichia coli. Biotechnology (NY). 1991, 9: 443-448. 10.1038/nbt0591-443.CrossRef
8.
go back to reference Smith JD, Subramanian G, Gamain B, Baruch DI, Miller LH: Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family. Mol Biochem Parasitol. 2000, 110: 293-310. 10.1016/S0166-6851(00)00279-6.CrossRefPubMed Smith JD, Subramanian G, Gamain B, Baruch DI, Miller LH: Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family. Mol Biochem Parasitol. 2000, 110: 293-310. 10.1016/S0166-6851(00)00279-6.CrossRefPubMed
9.
go back to reference Chen Q, Barragan A, Fernandez V, Sundstrom A, Schlichtherle M, Sahlen A, Carlson J, Datta S, Wahlgren M: Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum. J Exp Med. 1998, 187: 15-23. 10.1084/jem.187.1.15.PubMedCentralCrossRefPubMed Chen Q, Barragan A, Fernandez V, Sundstrom A, Schlichtherle M, Sahlen A, Carlson J, Datta S, Wahlgren M: Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum. J Exp Med. 1998, 187: 15-23. 10.1084/jem.187.1.15.PubMedCentralCrossRefPubMed
10.
go back to reference Wahlgren M, Abrams JS, Fernandez V, Bejarano MT, Azuma M, Torii M, Aikawa M, Howard RJ: Adhesion of Plasmodium falciparum-infected erythrocytes to human cells and secretion of cytokines (IL-1-beta, IL-1RA, IL-6, IL-8, IL-10, TGF beta, TNF alpha, G-CSF, GM-CSF. Scand J Immunol. 1995, 42: 626-36.CrossRefPubMed Wahlgren M, Abrams JS, Fernandez V, Bejarano MT, Azuma M, Torii M, Aikawa M, Howard RJ: Adhesion of Plasmodium falciparum-infected erythrocytes to human cells and secretion of cytokines (IL-1-beta, IL-1RA, IL-6, IL-8, IL-10, TGF beta, TNF alpha, G-CSF, GM-CSF. Scand J Immunol. 1995, 42: 626-36.CrossRefPubMed
11.
go back to reference Springer AL, Smith LM, Mackay DQ, Nelson SO, Smith JD: Functional interdependence of the DBLbeta domain and c2 region for binding of the Plasmodium falciparum variant antigen to ICAM-1. Mol Biochem Parasitol. 2004, 137: 55-64. 10.1016/j.molbiopara.2004.03.019.CrossRefPubMed Springer AL, Smith LM, Mackay DQ, Nelson SO, Smith JD: Functional interdependence of the DBLbeta domain and c2 region for binding of the Plasmodium falciparum variant antigen to ICAM-1. Mol Biochem Parasitol. 2004, 137: 55-64. 10.1016/j.molbiopara.2004.03.019.CrossRefPubMed
12.
go back to reference Koschorreck M, Fischer M, Barth S, Pleiss J: How to find soluble proteins: a comprehensive analysis of alpha/beta hydrolases for recombinant expression in E. coli. BMC Genomics. 2005, 6: 49-59. 10.1186/1471-2164-6-49.PubMedCentralCrossRefPubMed Koschorreck M, Fischer M, Barth S, Pleiss J: How to find soluble proteins: a comprehensive analysis of alpha/beta hydrolases for recombinant expression in E. coli. BMC Genomics. 2005, 6: 49-59. 10.1186/1471-2164-6-49.PubMedCentralCrossRefPubMed
13.
go back to reference Cornvik T, Dahlroth SL, Magnusdottir A, Herman MD, Knaust R, Ekberg M, Nordlund P: Colony filtration blot: a new screening method for soluble protein expression in Escherichia coli. Nat Methods. 2005, 2: 507-509. 10.1038/nmeth767.CrossRefPubMed Cornvik T, Dahlroth SL, Magnusdottir A, Herman MD, Knaust R, Ekberg M, Nordlund P: Colony filtration blot: a new screening method for soluble protein expression in Escherichia coli. Nat Methods. 2005, 2: 507-509. 10.1038/nmeth767.CrossRefPubMed
14.
go back to reference Sati SP, Singh SK, Kumar N, Sharma A: Extra terminal residues have a profound effect on the folding and solubility of a Plasmodium falciparum sexual stage-specific protein over-expressed in Escherichia coli. Eur J Biochem. 2002, 269: 5259-5263. 10.1046/j.1432-1033.2002.03237.x.CrossRefPubMed Sati SP, Singh SK, Kumar N, Sharma A: Extra terminal residues have a profound effect on the folding and solubility of a Plasmodium falciparum sexual stage-specific protein over-expressed in Escherichia coli. Eur J Biochem. 2002, 269: 5259-5263. 10.1046/j.1432-1033.2002.03237.x.CrossRefPubMed
15.
go back to reference Kane JF, Hartley DL: Properties of recombinant protein-containing inclusion bodies in Escherichia coli. Bioprocess Technol. 1991, 12: 121-145.PubMed Kane JF, Hartley DL: Properties of recombinant protein-containing inclusion bodies in Escherichia coli. Bioprocess Technol. 1991, 12: 121-145.PubMed
16.
go back to reference Luan CH, Qiu S, Finley JB, Carson M, Gray RJ, Huang W, Johnson D, Tsao J, Reboul J, Vaglio P, Hill DE, Vidal M, Delucas LJ, Luo M: High-throughput expression of C. elegans proteins. Genome Res. 2004, 14: 2102-2110. 10.1101/gr.2520504.PubMedCentralCrossRefPubMed Luan CH, Qiu S, Finley JB, Carson M, Gray RJ, Huang W, Johnson D, Tsao J, Reboul J, Vaglio P, Hill DE, Vidal M, Delucas LJ, Luo M: High-throughput expression of C. elegans proteins. Genome Res. 2004, 14: 2102-2110. 10.1101/gr.2520504.PubMedCentralCrossRefPubMed
17.
go back to reference Singh S, Pandey K, Chattopadhayay R, Yazdani SS, Lynn A, Bharadwaj A, Ranjan A, Chitnis C: Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax duffy-binding protein. J Biol Chem. 2001, 276: 17111-17116. 10.1074/jbc.M101531200.CrossRefPubMed Singh S, Pandey K, Chattopadhayay R, Yazdani SS, Lynn A, Bharadwaj A, Ranjan A, Chitnis C: Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax duffy-binding protein. J Biol Chem. 2001, 276: 17111-17116. 10.1074/jbc.M101531200.CrossRefPubMed
18.
go back to reference Giersing B, Miura K, Shimp R, Wang J, Zhou H, Orcutt A, Stowers A, Saul A, Miller LH, Long C, Singh S: Posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate. Infect Immun. 2005, 73: 3963-3970. 10.1128/IAI.73.7.3963-3970.2005.PubMedCentralCrossRefPubMed Giersing B, Miura K, Shimp R, Wang J, Zhou H, Orcutt A, Stowers A, Saul A, Miller LH, Long C, Singh S: Posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate. Infect Immun. 2005, 73: 3963-3970. 10.1128/IAI.73.7.3963-3970.2005.PubMedCentralCrossRefPubMed
19.
go back to reference Singh S, Kennedy MC, Long CA, Saul AJ, Miller LH, Stowers AW: Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1. Infect Immun. 2003, 71: 6766-6774. 10.1128/IAI.71.12.6766-6774.2003.PubMedCentralCrossRefPubMed Singh S, Kennedy MC, Long CA, Saul AJ, Miller LH, Stowers AW: Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1. Infect Immun. 2003, 71: 6766-6774. 10.1128/IAI.71.12.6766-6774.2003.PubMedCentralCrossRefPubMed
Metadata
Title
Prediction of solubility on recombinant expression of Plasmodium falciparum erythrocyte membrane protein 1 domains in Escherichia coli
Authors
Sanjay Ahuja
Satpal Ahuja
Qijun Chen
Mats Wahlgren
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2006
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-5-52

Other articles of this Issue 1/2006

Malaria Journal 1/2006 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.